Alembic announces successful USFDA inspection at joint venture
Aleor Dermaceuticals Ltd., a 60:40 joint venture between Alembic Pharmaceuticals Ltd. and Orbicular Pharmaceutical Technologies Pvt. Ltd., has successfully cleared its first US FDA inspection of its new formulation facility located at Karakhadi, Gujarat, without any observations. The scheduled inspection was carried out between October 15-19, 2018.
Aleor was formed in April 2016 to develop, manufacture and commercialise dermatology products for worldwide markets. Till date the company has filed six ANDAs.
“This is a result of the dedication, commitment and focus of the entire Aleor team to ensure highest quality standards are maintained and we are very excited to build this organisation on a global platform,” said Dr. M.S. Mohan, Founder and Managing Director of Orbicular.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-08-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
GM Crop Area Reaches 216 Million Hectares
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
Recommend Reading
-
![Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated]()
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
![Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy]()
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
![The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030]()
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
![Jinggong Tech H1 Net Profit Soars 15 Percent Revenue Reaches 1.06 Billion Yuan Carbon Fiber Equipment Drives 59 Percent of Sales]()
Jinggong Tech H1 Net Profit Soars 15 Percent Revenue Reaches 1.06 Billion Yuan Carbon Fiber Equipment Drives 59 Percent of Sales
-
![EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry]()
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
![Premium Global Chemical Sourcing Requests (8-12 Dec 2025)]()
Premium Global Chemical Sourcing Requests (8-12 Dec 2025)
-
![Key Reactions and Uses of Lithium Aluminum Hydride]()
Key Reactions and Uses of Lithium Aluminum Hydride
-
![Uses and Properties of 3-Methyl-1-Butanol]()
Uses and Properties of 3-Methyl-1-Butanol
-
![Premium Global Chemical Sourcing Requests (23–27 Aug 2025)]()
Premium Global Chemical Sourcing Requests (23–27 Aug 2025)
-
![Polyester Bottle Flakes in January Show Initial Weakness, Then Strengthen, Climbing to a Peak at Month’s End Before Reversing]()
Polyester Bottle Flakes in January Show Initial Weakness, Then Strengthen, Climbing to a Peak at Month’s End Before Reversing
